Relapsing Remitting Multiple Sclerosis (RRMS) research hub

Multicenter, Phase Ib/IIa Study on the Safety and Efficacy of Autologous Peptide-coupled Red Blood Cells in Patients with Relapsing Remitting Multiple Sclerosis

This study is testing a new way to treat Relapsing Remitting Multiple Sclerosis (RRMS). It uses your own red blood cells, specially prepared, to see if they are safe and help reduce MS symptoms and new brain lesions. It's an early-stage study, focusing on safety.